ES2086038T3 - Procedimiento para la determinacion de fibrina. - Google Patents

Procedimiento para la determinacion de fibrina.

Info

Publication number
ES2086038T3
ES2086038T3 ES92116414T ES92116414T ES2086038T3 ES 2086038 T3 ES2086038 T3 ES 2086038T3 ES 92116414 T ES92116414 T ES 92116414T ES 92116414 T ES92116414 T ES 92116414T ES 2086038 T3 ES2086038 T3 ES 2086038T3
Authority
ES
Spain
Prior art keywords
fibrin
determination
procedure
thiocyanate
iodide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92116414T
Other languages
English (en)
Inventor
Andreas Dr Dessauer
Helmut Dr Lill
Werner Dr Naser
Beatus Dr Ofenloch-Hahnle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2086038T3 publication Critical patent/ES2086038T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Auxiliary Devices For Music (AREA)
  • Paper (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO MEJORADO PARA LA DETERMINACION DE LA FIBRINA EN FLUIDOS CORPORALES, EN EL QUE LA DISOLUCION DE MUESTRA CONTENIENDO FIBRINA ANTES DE LA PROPIA DETERMINACION, SE INCUBA EN PRESENCIA DE IONES DE SULFOCIANURO, YODURO, MAGNESIO O/Y GUANIDINA.
ES92116414T 1991-09-25 1992-09-24 Procedimiento para la determinacion de fibrina. Expired - Lifetime ES2086038T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4131953 1991-09-25
DE4134833A DE4134833A1 (de) 1991-09-25 1991-10-22 Verfahren zur bestimmung von fibrin

Publications (1)

Publication Number Publication Date
ES2086038T3 true ES2086038T3 (es) 1996-06-16

Family

ID=25907702

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92116414T Expired - Lifetime ES2086038T3 (es) 1991-09-25 1992-09-24 Procedimiento para la determinacion de fibrina.

Country Status (6)

Country Link
US (1) US5441869A (es)
EP (1) EP0534444B1 (es)
JP (1) JP2501518B2 (es)
AT (1) ATE136122T1 (es)
DE (2) DE4134833A1 (es)
ES (1) ES2086038T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69435072T2 (de) * 1993-11-02 2009-01-29 Mitsubishi Kagaku Iatron, Inc. Antikörper gegen menschliches lösliches fibrin, hybridome, die sie produzieren und immunmessverfahren
DE4434093A1 (de) * 1994-09-23 1996-03-28 Boehringer Mannheim Gmbh Verfahren zum qualitativen oder/und quantitativen Nachweis einer zu bestimmenden Substanz
US5962340A (en) * 1994-11-02 1999-10-05 Wako Pure Chemical Industries Ltd. Homogeneous immunoassay method utilizing 5-300 mM magnesium
WO2003078962A2 (en) * 2002-03-11 2003-09-25 President And Fellows Of Harvard College Detection and quantification of modified proteins
DE10222234A1 (de) * 2002-05-16 2003-11-27 Roche Diagnostics Gmbh Kontroll- und Kalibrationsmaterial für Blutgerinnungstests
CN116819104A (zh) * 2023-06-16 2023-09-29 武汉明德生物科技股份有限公司 硫氰酸钠在制备用于凝血项目检测的试剂盒中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3400434A1 (de) * 1984-01-09 1985-09-26 Behringwerke Ag, 3550 Marburg Bestimmung von fibrin mit fibrin-spezifischen antikoerpern
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
DE3730059A1 (de) * 1987-09-08 1989-03-30 Behringwerke Ag Verfahren zur bestimmung von "loeslichem" fibrin
US5120834A (en) * 1988-06-13 1992-06-09 American Biogenetic Sciences, Inc. Fibrin-specific monoclonal antibody
US5091512A (en) * 1988-06-13 1992-02-25 American Biogenetic Sciences, Inc. Fibrinogen-specific monoclonal antibody
DE3829245A1 (de) * 1988-08-29 1990-03-01 Boehringer Mannheim Gmbh Verfahren zur bestimmung einer spezifisch bindefaehigen substanz

Also Published As

Publication number Publication date
EP0534444A1 (de) 1993-03-31
JPH07198720A (ja) 1995-08-01
DE4134833A1 (de) 1993-04-01
ATE136122T1 (de) 1996-04-15
DE59205827D1 (de) 1996-05-02
US5441869A (en) 1995-08-15
EP0534444B1 (de) 1996-03-27
JP2501518B2 (ja) 1996-05-29

Similar Documents

Publication Publication Date Title
NO932855L (no) Fremgangsmaate og materiale for bestemmelse av kaliumioneri fluider
ATE59412T1 (de) Charakterisierung von onkogenen und darauf beruhende bestimmungen.
ES2141073T1 (es) Nuevos reactivos y metodo de lisis de eritrocitos.
GB2148512B (en) Measuring probe for the potentiometric determination of ion concentrations, process for its manufacture and its application
DE3576853D1 (de) Ultraschall-koagulationsanzeiger und methode zum nachweis des eintretens von koagulation.
BR9507690A (pt) Detecção de reticulócitos
ATE111228T1 (de) Verfahren zur überwachung des kollagenabbaus.
DE59208032D1 (de) Funktioneller Test und Reagenz zur Bestimmung von Fibrinogen
NO864775D0 (no) Middel til bestemmelse av peroksydase-aktivitet med stabilisator, fremgangsmaate til dets fremstilling og dets anvendelse.
DE69032422D1 (de) Reagenzzusammensetzung, Verfahren und Kits zur Quantifizierung von Magnesium oder Calcium und Magnesium
DE59109048D1 (de) Inhibitoren zur antikoagulierenden Vorbehandung von Blutproben
ATE154439T1 (de) Verfahren zur bestimmung der ionenstärke oder des spezifischen gewichts von wässrigen flüssigkeiten
ATE347697T1 (de) Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten
ES2179081T3 (es) Procedimiento para la deteccion de perturbaciones del sistema de proteina c/proteina s.
MX169931B (es) Procedimiento para determinar la catividad de serinproteasas inhibidores de serinproteasas
ES516496A0 (es) "procedimiento para la determinacion de hemoglobina glucosilada".
ES517034A0 (es) Metodo de deteccion de grietas superficiales en piezas, particularmente en tochos.
DE59205827D1 (de) Verfahren zur Bestimmung von Fibrin
FI854627A7 (fi) Menetelmä ja reagenssi plasmassa, seerumissa tai kokoveressä olevan vapaan tyroksiinin kvantitatiiviseksi määrittämiseksi.
AU697417B2 (en) Additive for diagnostic tests for determination of the coagulability of blood, method of reducing the influencing of diagnostic tests by heparin and the use of metal salts for these purposes
DE3765147D1 (de) Verfahren und reagenz zur bestimmung von gesamt-bilirubin.
AU2353188A (en) A diagnostic agent and a method for the determination of apolipoprotein b
NO160554C (no) Reagens for bestemmelse av ristocetin-kofaktoren (willebrand-faktor).
ES2136272T3 (es) Procedimientos de ensayo y dispositivos para los mismos.
EP0217768A3 (en) Method and compositions for heparin assays

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 534444

Country of ref document: ES